NEW YORK (GenomeWeb) – Meridian Bioscience today announced it has received the CE Mark for its Illumigene Malaria test, developed with the US Centers for Disease Control and Prevention and Senegal's Cheikh Anta Diop University.

Using loop-mediated isothermal amplification technology, Illumigene Malariaresults are available in under an hour and are 80,000 times more sensitive at detecting the malaria parasite than conventional tests, the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.